CRL short interest
Charles River Laboratories International Inc. · Healthcare · Medical - Diagnostics & Research · settlement date 2026-09-30
| Shares short | 2,878,537 |
|---|---|
| Change vs prior report | 648,020 (+29.1%) |
| Change over six months | -37.4% |
| Days to cover | 2.69 (sector: 3.78) |
| Average daily volume | 1,071,070 |
| Rank in Healthcare | #659 of 922 by days to cover |
CRL short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 2,878,537 | +29.1% | 2.69 | 1,071,070 |
| 2026-09-15 | 2,230,517 | -12.0% | 2.75 | 811,691 |
| 2026-08-31 | 2,535,053 | +7.4% | 2.78 | 913,007 |
| 2026-08-14 | 2,360,745 | -31.0% | 2.22 | 1,063,448 |
| 2026-07-31 | 3,419,974 | +2.3% | 4.06 | 841,792 |
| 2026-07-15 | 3,343,526 | -23.2% | 3.99 | 837,232 |
| 2026-06-30 | 4,354,792 | +20.5% | 4.26 | 1,023,068 |
| 2026-06-15 | 3,612,693 | -7.3% | 5.23 | 690,301 |
| 2026-05-29 | 3,897,904 | +7.3% | 3.62 | 1,077,274 |
| 2026-05-15 | 3,632,420 | +8.5% | 3.83 | 948,967 |
| 2026-04-30 | 3,349,211 | -28.2% | 4.54 | 738,302 |
| 2026-04-15 | 4,666,350 | +1.6% | 5.44 | 858,041 |
| 2026-03-31 | 4,594,794 | +22.3% | 5.33 | 861,926 |
| 2026-03-13 | 3,756,012 | +6.2% | 3.99 | 942,258 |
| 2026-02-27 | 3,537,661 | +19.8% | 2.24 | 1,579,421 |
| 2026-02-13 | 2,953,939 | +9.9% | 2.41 | 1,226,108 |
| 2026-01-30 | 2,688,327 | -5.2% | 4.89 | 549,558 |
| 2026-01-15 | 2,835,349 | +10.2% | 3.41 | 832,194 |
| 2025-12-31 | 2,571,745 | +6.7% | 4.82 | 533,483 |
| 2025-12-15 | 2,409,632 | -6.4% | 2.95 | 817,021 |
| 2025-11-28 | 2,574,051 | -4.8% | 2.97 | 865,662 |
| 2025-11-14 | 2,703,341 | +11.0% | 1.98 | 1,366,702 |
| 2025-10-31 | 2,434,747 | +16.6% | 2.12 | 1,146,411 |
| 2025-10-15 | 2,087,410 | -5.4% | 2.25 | 928,524 |
| 2025-09-30 | 2,207,028 | -13.9% | 2.22 | 995,861 |
import finzdata as yf
yf.Ticker("CRL").short_interest # every report since 2017
yf.Client().short_interest(["CRL"], start="2018-01-01")Healthcare short interest · CRL price history · Who owns CRL · All short interest